NYSE:DHR - Danaher Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $215.53
  • Forecasted Upside: -0.58 %
  • Number of Analysts: 13
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 11 Buy Ratings
  • 0 Strong Buy Ratings
$216.78
▼ -0.44 (-0.20%)
1 month | 3 months | 12 months
Get New Danaher Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DHR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DHR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$215.53
▼ -0.58% Downside Potential
This price target is based on 13 analysts offering 12 month price targets for Danaher in the last 3 months. The average price target is $215.53, with a high forecast of $280.00 and a low forecast of $169.00. The average price target represents a -0.58% upside from the last price of $216.78.
Buy
The current consensus among 13 investment analysts is to buy stock in Danaher. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/8/2019
  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/6/2019
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/5/2019
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/4/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/2/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/31/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/30/2020
  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/29/2020

Latest Recommendations

  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/25/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$273.00 ➝ $234.00Low
i
11/9/2020KeyCorpInitiated CoverageOverweight$280.00High
i
10/27/2020Needham & Company LLCBoost Price Target$209.00 ➝ $272.00Low
i
10/23/2020Royal Bank of CanadaBoost Price TargetOutperform$250.00 ➝ $273.00Medium
i
10/23/2020Robert W. BairdBoost Price TargetOutperform$205.00 ➝ $252.00Medium
i
9/29/2020Wells Fargo & CompanyReiterated RatingBuy$234.00Low
i
7/27/2020Needham & Company LLCBoost Price TargetBuy$183.00 ➝ $209.00Low
i
7/27/2020UBS GroupBoost Price TargetBuy$176.00 ➝ $233.00Low
i
7/24/2020Stifel NicolausBoost Price TargetHold$170.00 ➝ $210.00Low
i
7/24/2020Jefferies Financial GroupBoost Price TargetBuy$190.00 ➝ $230.00Low
i
7/24/2020Robert W. BairdBoost Price TargetOutperform$163.00 ➝ $205.00Medium
i
Rating by Richard Eastman at Robert W. Baird
7/24/2020Royal Bank of CanadaBoost Price TargetOutperform$205.00 ➝ $218.00Medium
i
Rating by Deane Dray at Royal Bank of Canada
7/20/2020Bank of AmericaBoost Price TargetBuy$181.00 ➝ $215.00Low
i
7/20/2020Royal Bank of CanadaReiterated RatingBuy$205.00Low
i
Rating by Deane Dray at Royal Bank of Canada
6/16/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$195.00Low
i
5/21/2020Credit Suisse GroupBoost Price TargetOutperform$165.00 ➝ $169.00Low
i
5/15/2020Needham & Company LLCLower Price TargetBuy$187.00 ➝ $183.00High
i
5/11/2020Royal Bank of CanadaBoost Price TargetIn-Line ➝ Outperform$159.00 ➝ $173.00Low
i
Rating by Deane Dray at Royal Bank of Canada
5/8/2020Stifel NicolausBoost Price TargetHold$147.00 ➝ $170.00Low
i
5/8/2020CitigroupBoost Price TargetBuy$180.00 ➝ $190.00High
i
5/7/2020Bank of AmericaBoost Price TargetBuy$160.00 ➝ $181.00Medium
i
4/21/2020Wells Fargo & CompanyBoost Price TargetOverweight$155.00 ➝ $170.00Medium
i
4/20/2020CitigroupBoost Price TargetBuy$160.00 ➝ $180.00Low
i
4/2/2020Stifel NicolausLower Price TargetHold$162.00 ➝ $147.00Medium
i
4/2/2020Wolfe ResearchDowngradeOutperform ➝ Market Perform$154.00High
i
Rating by Steve Beuchaw at Wolfe Research
3/30/2020Wells Fargo & CompanyLower Price TargetOverweight$176.00 ➝ $155.00Medium
i
3/26/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector PerformLow
i
Rating by Deane Dray at Royal Bank of Canada
3/25/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$151.00 ➝ $157.00High
i
Rating by Deane Dray at Royal Bank of Canada
3/23/2020Robert W. BairdReiterated RatingBuy$136.00High
i
Rating by Richard Eastman at Robert W. Baird
3/20/2020CitigroupLower Price TargetBuy$195.00 ➝ $160.00Medium
i
2/3/2020CowenReiterated RatingBuy$170.00High
i
2/3/2020Needham & Company LLCBoost Price TargetBuy$167.00 ➝ $187.00Low
i
1/31/2020Bank of AmericaBoost Price TargetBuy$165.00 ➝ $188.00Low
i
1/31/2020Robert W. BairdBoost Price TargetOutperform$160.00 ➝ $175.00High
i
1/31/2020Stifel NicolausBoost Price TargetHold$150.00 ➝ $162.00High
i
1/31/2020CitigroupBoost Price TargetBuy$180.00 ➝ $195.00High
i
1/30/2020Piper SandlerBoost Price Target$142.00 ➝ $174.00High
i
1/10/2020UBS GroupBoost Price TargetNeutral$165.00 ➝ $176.00Low
i
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$170.00Low
i
1/6/2020CitigroupInitiated CoverageBuy$180.00Low
i
1/2/2020Needham & Company LLCBoost Price TargetBuy$152.00 ➝ $167.00Low
i
Rating by Stephen Unger at Needham & Company LLC
12/19/2019JPMorgan Chase & Co.Boost Price Target$155.00 ➝ $175.00Medium
i
12/19/2019Credit Suisse GroupBoost Price TargetOutperform$151.00 ➝ $160.00Low
i
12/18/2019Royal Bank of CanadaReiterated RatingHold$145.00Medium
i
Rating by Deane Dray at Royal Bank of Canada
12/2/2019UBS GroupBoost Price TargetBuy$158.00 ➝ $165.00Low
i
11/14/2019Stifel NicolausReiterated RatingHold$150.00High
i
10/28/2019Needham & Company LLCLower Price TargetBuy$155.00 ➝ $152.00Low
i
Rating by Stephen Unger at Needham & Company LLC
10/25/2019Wolfe ResearchSet Price TargetBuy$154.00N/A
i
Rating by Steve Beuchaw at Wolfe Research
10/14/2019Credit Suisse GroupReiterated RatingOutperform$151.00Low
i
9/26/2019Wolfe ResearchSet Price TargetBuy$157.00Medium
i
Rating by Steve Beuchaw at Wolfe Research
7/23/2019ArgusBoost Price TargetBuy$165.00Low
i
7/19/2019Royal Bank of CanadaSet Price TargetHold$134.00Low
i
Rating by Deane Dray at Royal Bank of Canada
7/19/2019Robert W. BairdBoost Price TargetOutperform$131.00 ➝ $148.00Low
i
7/19/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$142.00 ➝ $155.00Low
i
Rating by Stephen Unger at Needham & Company LLC
7/18/2019Piper Jaffray CompaniesBoost Price TargetNeutral$148.00 ➝ $153.00Low
i
6/11/2019Piper Jaffray CompaniesInitiated CoverageNeutral ➝ Neutral$148.00Low
i
5/30/2019Wolfe ResearchInitiated CoverageOutperform ➝ OutperformMedium
i
4/17/2019Janney Montgomery ScottBoost Price TargetBuy$136.00 ➝ $174.00Medium
i
4/17/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$138.00 ➝ $141.00High
i
Rating by Stephen Unger at Needham & Company LLC
3/4/2019JPMorgan Chase & Co.Reiterated RatingOverweight$140.00Medium
i
2/28/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$114.00 ➝ $138.00Low
i
2/26/2019Jefferies Financial GroupBoost Price TargetBuy$140.00Medium
i
2/26/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy$130.00Medium
i
2/26/2019UBS GroupBoost Price TargetBuy$125.00 ➝ $144.00Medium
i
2/25/2019Janney Montgomery ScottUpgradeNeutral ➝ BuyHigh
i
1/7/2019CowenReiterated RatingBuy$110.00Low
i
1/2/2019Needham & Company LLCInitiated CoverageBuy ➝ Buy$114.00High
i
12/19/2018Royal Bank of CanadaReiterated RatingHold$102.00High
i
10/19/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$116.00 ➝ $114.00Medium
i
10/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$122.00 ➝ $126.00High
i
7/20/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$120.00 ➝ $122.00Medium
i
7/19/2018Royal Bank of CanadaBoost Price TargetSector Perform ➝ Positive$107.00Medium
i
7/19/2018Bank of AmericaSet Price TargetBuy$113.00Medium
i
7/13/2018Morgan StanleyBoost Price TargetOverweight$113.00 ➝ $120.00Low
i
4/20/2018BarclaysReiterated RatingBuy$113.00Low
i
4/20/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$112.00 ➝ $113.00Low
i
4/20/2018Jefferies Financial GroupReiterated RatingBuy$117.00Low
i
4/20/2018Robert W. BairdReiterated RatingBuy$106.00Low
i
4/19/2018Stifel NicolausReiterated RatingBuy ➝ Buy$108.00 ➝ $114.00Low
i
4/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$110.00 ➝ $112.00Low
i
3/13/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$106.00 ➝ $108.00Low
i
3/9/2018Credit Suisse GroupReiterated RatingHold ➝ OutperformLow
i
3/1/2018Deutsche Bank AktiengesellschaftLower Price TargetBuy ➝ Buy$114.00 ➝ $107.00Low
i
2/15/2018BarclaysInitiated CoverageOverweight ➝ Overweight$110.00Low
i
2/1/2018ArgusBoost Price TargetBuy$100.00 ➝ $115.00Low
i
1/31/2018Royal Bank of CanadaReiterated RatingHold$98.00Low
i
1/31/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$110.00 ➝ $115.00Low
i
1/31/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$103.00 ➝ $110.00Low
i
1/31/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$99.00 ➝ $105.00Low
i
1/30/2018CowenReiterated RatingBuy$110.00Low
i
1/22/2018UBS GroupInitiated CoverageBuy$116.00 ➝ $99.97Low
i
1/19/2018Stifel NicolausReiterated RatingBuy$110.00Low
i
1/12/2018Robert W. BairdReiterated RatingBuyLow
i
1/4/2018Royal Bank of CanadaReiterated RatingHold$96.00Low
i
1/3/2018Evercore ISIInitiated CoverageOutperformLow
i
12/19/2017Credit Suisse GroupReiterated RatingHold$99.00Low
i
12/15/2017Robert W. BairdReiterated RatingBuy$99.00Low
i
12/15/2017CitigroupBoost Price TargetBuy$107.00High
i
Rating by Andrew Kaplowitz at Citigroup Inc.
10/20/2017Robert W. BairdBoost Price TargetOutperform$87.00 ➝ $97.00N/A
i
10/20/2017Credit Suisse GroupBoost Price TargetOutperform$93.00 ➝ $96.00N/A
i
10/20/2017Morgan StanleyBoost Price TargetOverweight$95.00 ➝ $98.00N/A
i
10/6/2017Morgan StanleyReiterated RatingOverweight$86.00 ➝ $95.00N/A
i
10/4/2017CowenReiterated RatingBuy$90.00Low
i
9/26/2017The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$83.00Low
i
9/8/2017JPMorgan Chase & Co.Reiterated RatingOverweight$95.00Low
i
8/4/2017Jefferies Financial GroupReiterated RatingBuy$95.00Low
i
7/22/2017Wells Fargo & CompanyReiterated RatingMarket PerformLow
i
7/21/2017CitigroupSet Price TargetBuy$98.00 ➝ $96.00Low
i
7/13/2017Wells Fargo & CompanyInitiated CoverageMarket Perform ➝ Market Perform$90.00Medium
i
7/12/2017Royal Bank of CanadaReiterated RatingHold$88.00Low
i
6/21/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$97.00Low
i
6/7/2017Janney Montgomery ScottDowngradeBuy ➝ NeutralLow
i
5/24/2017Credit Suisse GroupReiterated RatingBuy$93.00Low
i
4/23/2017William BlairReiterated RatingOutperformLow
i
4/23/2017CowenReiterated RatingOutperform$90.00Low
i
4/23/2017BTIG ResearchReiterated RatingBuy$92.00Low
i
4/21/2017Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$89.00 ➝ $88.00High
i
2/24/2017CitigroupUpgradeNeutral ➝ Buy$98.00N/A
i
2/1/2017Jefferies Financial GroupBoost Price TargetBuy$93.00 ➝ $95.00N/A
i
2/1/2017Credit Suisse GroupUpgradeNeutral ➝ Outperform$80.00 ➝ $93.00N/A
i
1/31/2017Evercore ISIBoost Price TargetBuy$88.50 ➝ $91.50N/A
i
1/18/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$88.00N/A
i
1/2/2017Royal Bank of CanadaSet Price TargetHold$84.00N/A
i
Rating by Deane Dray at Royal Bank of Canada
12/15/2016Sanford C. BernsteinReiterated RatingOutperformN/A
i
Rating by Steven Winoker at Sanford C. Bernstein
12/13/2016Morgan StanleyReiterated RatingOverweightN/A
i
Rating by nigel coe at Morgan Stanley
11/11/2016CowenUpgradeMarket Perform ➝ Outperform$95.00N/A
i
10/21/2016Royal Bank of CanadaSet Price TargetHold$85.00 ➝ $86.00N/A
i
Rating by Deane Dray at Royal Bank of Canada
10/12/2016Evercore ISIReiterated RatingBuy$89.00N/A
i
10/6/2016JPMorgan Chase & Co.Reiterated RatingBuy$90.00N/A
i
Rating by Stephen Tusa at JPMorgan Chase & Co.
9/8/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
9/7/2016BarclaysBoost Price TargetOverweight$90.00 ➝ $91.00N/A
i
Rating by Scott Davis at Barclays PLC
8/31/2016Morgan StanleyReiterated RatingBuy$86.00N/A
i
8/2/2016CitigroupReiterated RatingMarket Perform$85.00N/A
i
Rating by Andrew Kaplowitz at Citigroup Inc.
8/2/2016CowenInitiated CoverageMarket PerformN/A
i
7/28/2016ArgusReiterated RatingBuy$110.00 ➝ $90.00N/A
i
7/27/2016BarclaysReiterated RatingOverweight$90.00N/A
i
Rating by Scott Davis at Barclays PLC
7/27/2016CitigroupBoost Price TargetNeutral$81.00 ➝ $84.00N/A
i
Rating by Andrew Kaplowitz at Citigroup Inc.
7/26/2016Jefferies Financial GroupBoost Price TargetBuy$92.00 ➝ $93.00N/A
i
7/25/2016Credit Suisse GroupReiterated RatingHoldN/A
i
Rating by Julian Mitchell at Credit Suisse Group AG
7/15/2016UBS GroupReiterated RatingBuy$108.00 ➝ $92.00N/A
i
7/15/2016Jefferies Financial GroupReiterated RatingBuy$105.00 ➝ $92.00N/A
i
7/12/2016JPMorgan Chase & Co.Initiated CoverageNeutralN/A
i
Rating by Stephen Tusa at JPMorgan Chase & Co.
7/11/2016BarclaysReiterated RatingOverweight$105.00 ➝ $86.00N/A
i
Rating by Scott Davis at Barclays PLC
7/9/2016Credit Suisse GroupReiterated RatingHoldN/A
i
Rating by Julian Mitchell at Credit Suisse Group AG
7/5/2016CitigroupReiterated RatingNeutralN/A
i
Rating by Andrew Kaplowitz at Citigroup Inc.
7/5/2016The Goldman Sachs GroupInitiated CoverageNeutral$74.00N/A
i
6/30/2016JPMorgan Chase & Co.Reiterated RatingBuy$105.00N/A
i
6/27/2016BarclaysReiterated RatingOverweight$105.00N/A
i
Rating by Scott Davis at Barclays PLC
6/23/2016Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform$120.00N/A
i
Rating by Steven Winoker at Sanford C. Bernstein
6/13/2016Sanford C. BernsteinReiterated RatingHold$112.00N/A
i
Rating by Steven Winoker at Sanford C. Bernstein
6/13/2016CitigroupBoost Price TargetNeutral$102.00 ➝ $104.00N/A
i
Rating by Andrew Kaplowitz at Citigroup Inc.
5/29/2016Credit Suisse GroupReiterated RatingHoldN/A
i
Rating by Julian Mitchell at Credit Suisse Group AG
5/29/2016Bank of AmericaReiterated RatingBuyN/A
i
Rating by Andrew Obin at Bank of America Co.
5/27/2016Royal Bank of CanadaBoost Price TargetSector Perform$96.00 ➝ $99.00N/A
i
5/18/2016Morgan StanleyReiterated RatingBuy$106.00N/A
i
5/10/2016UBS GroupReiterated RatingBuy$103.00 ➝ $108.00N/A
i
4/25/2016SVB LeerinkReiterated RatingBuyN/A
i
4/25/2016Sterne Agee CRTBoost Price TargetNeutral$90.00 ➝ $97.00N/A
i
4/24/2016BarclaysBoost Price TargetOverweight$104.00 ➝ $105.00N/A
i
4/23/2016BarclaysReiterated RatingBuyN/A
i
Rating by Scott Davis at Barclays PLC
4/22/2016Stifel NicolausBoost Price TargetBuy$109.00 ➝ $110.00N/A
i
4/22/2016Royal Bank of CanadaBoost Price TargetSector Perform$87.00 ➝ $96.00N/A
i
4/19/2016CitigroupReiterated RatingNeutral$95.00 ➝ $101.00N/A
i
Rating by Andrew Kaplowitz at Citigroup Inc.
4/18/2016BarclaysLower Price TargetOverweight$104.00 ➝ $99.00N/A
i
4/17/2016Deutsche Bank AktiengesellschaftReiterated RatingHold$83.00N/A
i
4/12/2016The Goldman Sachs GroupBoost Price TargetNeutral$98.00 ➝ $99.00N/A
i
Rating by Isaac Ro at The Goldman Sachs Group, Inc.
4/4/2016Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$104.00 ➝ $105.00N/A
i
3/23/2016The Goldman Sachs GroupBoost Price Target$98.00N/A
i
Rating by Isaac Ro at The Goldman Sachs Group, Inc.
2/5/2016JPMorgan Chase & Co.Lower Price Target$102.00 ➝ $98.00N/A
i
1/27/2016The Goldman Sachs GroupLower Price TargetNeutral$91.00 ➝ $90.00N/A
i
Rating by Isaac Ro at The Goldman Sachs Group, Inc.
1/27/2016Credit Suisse GroupLower Price TargetNeutral$97.00 ➝ $90.00N/A
i
Rating by Julian Mitchell at Credit Suisse Group AG
1/27/2016Sanford C. BernsteinLower Price Target$110.00 ➝ $105.00N/A
i
1/27/2016Royal Bank of CanadaLower Price TargetSector Perform$93.00 ➝ $87.00N/A
i
1/27/2016BTIG ResearchReiterated RatingBuy$105.00N/A
i
Rating by Dane Leone at BTIG Research
1/21/2016Deutsche Bank AktiengesellschaftLower Price Target$88.00 ➝ $83.00N/A
i
Rating by John G. Inch at Deutsche Bank Aktiengesellschaft
1/21/2016CitigroupInitiated CoverageNeutral$95.00N/A
i
1/19/2016BarclaysBoost Price TargetOverweight$97.00 ➝ $99.00N/A
i
1/13/2016UBS GroupLower Price Target$108.00 ➝ $103.00N/A
i
12/17/2015BTIG ResearchReiterated RatingBuy$105.00N/A
i
Rating by Dane Leone at BTIG Research
12/17/2015BarclaysBoost Price TargetOverweight$94.00 ➝ $97.00N/A
i
12/14/2015Credit Suisse GroupBoost Price TargetNeutral$90.00 ➝ $97.00N/A
i
Rating by Julian Mitchell at Credit Suisse Group AG
12/11/2015JPMorgan Chase & Co.Boost Price Target$99.00 ➝ $102.00N/A
i
12/8/2015The Goldman Sachs GroupDowngradeBuy ➝ Neutral$104.00 ➝ $103.00N/A
i
12/4/2015BTIG ResearchReiterated RatingBuy$105.00N/A
i
Rating by Dane Leone at BTIG Research
12/4/2015Jefferies Financial GroupReiterated RatingBuy$105.00N/A
i
11/30/2015Sanford C. BernsteinBoost Price TargetOutperform$106.00 ➝ $110.00N/A
i
(Data available from 11/29/2015 forward)
Danaher logo
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Read More

Today's Range

Now: $216.78
$215.01
$218.55

50 Day Range

MA: $229.89
$217.22
$245.46

52 Week Range

Now: $216.78
$119.60
$248.32

Volume

1,407,208 shs

Average Volume

2,864,632 shs

Market Capitalization

$154.00 billion

P/E Ratio

43.88

Dividend Yield

0.33%

Beta

0.84